A leading member of the Senate said Wednesday that a prominent diabetes expert had leaked an unpublished and confidential medical journal article to GlaxoSmithKline last year, tipping the company to the imminent publication of safety questions involving the company’s diabetes drug Avandia.Click here to access the article.
Thursday, January 31, 2008
Leaky MD?
From the New York Times article:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment